The DNA damage response induces IFN

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5336-5345

  Brzostek Racine, Sabrina ^a   Gordon, Chris ^a   Van Scoy, Sarah ^a   Reich, Nancy C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 29; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL SURVIVAL; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA RECOMBINATION; DNA REPLICATION; DNA TRANSCRIPTION; EMBRYO; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; VIRUS INFECTION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-7; INTERFERONS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NEWCASTLE DISEASE VIRUS; SIGNAL TRANSDUCTION;

EID: 81455154853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100040     Document Type: Article

References (85)

1. Vilenchik, M. M., and A. G. Knudson. 2003. Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc. Natl. Acad. Sci. USA 100: 12871-12876. (Pubitemid 37339992)
2. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, and D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18: 495-527. (Pubitemid 30365389)
3. Richardson, C., N. Horikoshi, and T. K. Pandita. 2004. The role of the DNA double-strand break response network in meiosis. DNA Repair (Amst.) 3: 1149-1164. (Pubitemid 38997959)
4. Sinclair, A., S. Yarranton, and C. Schelcher. 2006. DNA-damage response pathways triggered by viral replication. Expert Rev. Mol. Med. 8: 1-11.
5. Mahaney, B. L., K. Meek, and S. P. Lees-Miller. 2009. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem. J. 417: 639-650.
6. Jackson, S. P., and J. Bartek. 2009. The DNA-damage response in human biology and disease. Nature 461: 1071-1078.
7. Su, T. T. 2006. Cellular responses to DNA damage: one signal, multiple choices. Annu. Rev. Genet. 40: 187-208. (Pubitemid 44956784)
8. Shiloh, Y. 2006. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31: 402-410. (Pubitemid 44038916)
9. Abraham, R. T. 2004. PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair (Amst.) 3: 883-887. (Pubitemid 38997930)
10. Elkon, R., S. Rashi-Elkeles, Y. Lerenthal, C. Linhart, T. Tenne, N. Amariglio, G. Rechavi, R. Shamir, and Y. Shiloh. 2005. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol. 6: R43.
11. Li, N., S. Banin, H. Ouyang, G. C. Li, G. Courtois, Y. Shiloh, M. Karin, and G. Rotman. 2001. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276: 8898-8903.
12. Fensterl, V., and G. C. Sen. 2009. Interferons and viral infections. Biofactors 35: 14-20.
13. Yoneyama, M., and T. Fujita. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20: 4-22.
14. Panne, D., T. Maniatis, and S. C. Harrison. 2007. An atomic model of the interferon-beta enhanceosome. Cell 129: 1111-1123.
15. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584. (Pubitemid 351600385)
16. Andersen, J., S. VanScoy, T. F. Cheng, D. Gomez, and N. C. Reich. 2008. IRF-3-dependent and augmented target genes during viral infection. Genes Immun. 9: 168-175. (Pubitemid 351351658)
17. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
18. Marié, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17: 6660-6669. (Pubitemid 28521799)
19. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264. (Pubitemid 28411130)
20. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662. (Pubitemid 34987786)
21. Onoguchi, K., M. Yoneyama, A. Takemura, S. Akira, T. Taniguchi, H. Namiki, and T. Fujita. 2007. Viral infections activate types I and III interferon genes through a common mechanism. J. Biol. Chem. 282: 7576-7581. (Pubitemid 47093699)
22. Osterlund, P. I., T. E. Pietilä, V. Veckman, S. V. Kotenko, and I. Julkunen. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 179: 3434-3442.
23. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6: 975-990. (Pubitemid 350201788)
24. Clemens, M. J. 2003. Interferons and apoptosis. J. Interferon Cytokine Res. 23: 277-292. (Pubitemid 36760748)
25. Li, W., A. Lewis-Antes, J. Huang, M. Balan, and S. V. Kotenko. 2008. Regulation of apoptosis by type III interferons. Cell Prolif. 41: 960-979.
26. Miller, C. H., S. G. Maher, and H. A. Young. 2009. Clinical Use of Interferongamma. Ann. N. Y. Acad. Sci. 1182: 69-79.
27. Makris, C., V. L. Godfrey, G. Krähn-Senftleben, T. Takahashi, J. L. Roberts, T. Schwarz, L. Feng, R. S. Johnson, and M. Karin. 2000. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5: 969-979.
28. Kimura, T., K. Nakayama, J. Penninger, M. Kitagawa, H. Harada, T. Matsuyama, N. Tanaka, R. Kamijo, J. Vilcek, T. W. Mak, et al. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924. (Pubitemid 24245636)
29. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
30. Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18: 1359-1368. (Pubitemid 28100900)
31. Kumar, K. P., K. M. McBride, B. K. Weaver, C. Dingwall, and N. C. Reich. 2000. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20: 4159-4168. (Pubitemid 30314513)
32. Banninger, G., and N. C. Reich. 2004. STAT2 nuclear trafficking. J. Biol. Chem. 279: 39199-39206.
33. McBride, K. M., C. McDonald, and N. C. Reich. 2000. Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor. EMBO J. 19: 6196-6206.
34. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92: 11259-11263. (Pubitemid 3015352)
35. Jura, N., E. Scotto-Lavino, A. Sobczyk, and D. Bar-Sagi. 2006. Differential modification of Ras proteins by ubiquitination. Mol. Cell 21: 679-687. (Pubitemid 43290734)
36. Zhang, L., and J. S. Pagano. 1997. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol. 17: 5748-5757. (Pubitemid 27411082)
37. Ank, N., H. West, C. Bartholdy, K. Eriksson, A. R. Thomsen, and S. R. Paludan. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80: 4501-4509.
38. Löseke, S., E. Grage-Griebenow, A. Wagner, K. Gehlhar, and A. Bufe. 2003. Differential expression of IFN-alpha subtypes in human PBMC: evaluation of novel real-time PCR assays. J. Immunol. Methods 276: 207-222. (Pubitemid 36513851)
39. Medhurst, A. D., D. C. Harrison, S. J. Read, C. A. Campbell, M. J. Robbins, and M. N. Pangalos. 2000. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 98: 9-20. (Pubitemid 30317436)
40. Gadberry, M. D., S. T. Malcomber, A. N. Doust, and E. A. Kellogg. 2005. Primaclade - a flexible tool to find conserved PCR primers across multiple species. Bioinformatics 21: 1263-1264. (Pubitemid 40467953)
41. Ank, N., M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, et al. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 180: 2474-2485.
42. Cheng, T. F., S. Brzostek, O. Ando, S. Van Scoy, K. P. Kumar, and N. C. Reich. 2006. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J. Immunol. 176: 7462-7470. (Pubitemid 43849049)
43. Tansey, W. P. 2006. Detection of ubiquitylated proteins in mammalian cells. Cold Spring Harb. Protoc. Available at: http://cshprotocols.cshlp.org/ content/2006/6/pdb.prot4616.abstract.
44. Weaver, B. K., O. Ando, K. P. Kumar, and N. C. Reich. 2001. Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53. FASEB J. 15: 501-515.
45. Heylbroeck, C., S. Balachandran, M. J. Servant, C. DeLuca, G. N. Barber, R. Lin, and J. Hiscott. 2000. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74: 3781-3792. (Pubitemid 30180321)
46. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249. (Pubitemid 36749609)
47. Baldwin, E. L., and N. Osheroff. 2005. Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents 5: 363-372. (Pubitemid 40974810)
48. Meresse, P., E. Dechaux, C. Monneret, and E. Bertounesque. 2004. Etoposide: discovery and medicinal chemistry. Curr. Med. Chem. 11: 2443-2466. (Pubitemid 39172359)
49. Reich, N. C., and L. Liu. 2006. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6: 602-612. (Pubitemid 44134093)
50. Aoki, R., and J. J. Kavanagh. 2004. Antineoplastic agents: classification and mechanisms of action. In Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches, 1st Ed. P. B. P. R. Angioli, J. J. Kavanagh, S. Pecorelli, and M. Penalver, eds. Marcel Dekker, New York, p. 1-12.
51. Génin, P., R. Lin, J. Hiscott, and A. Civas. 2009. Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 29: 3435-3450.
52. Hiscott, J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282: 15325-15329. (Pubitemid 47093257)
53. Au, W. C., P. A. Moore, D. W. LaFleur, B. Tombal, and P. M. Pitha. 1998. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem. 273: 29210-29217. (Pubitemid 28507622)
54. Caillaud, A., A. G. Hovanessian, D. E. Levy, and I. J. Marié. 2005. Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7. J. Biol. Chem. 280: 17671-17677. (Pubitemid 41389003)
55. Huye, L. E., S. Ning, M. Kelliher, and J. S. Pagano. 2007. Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol. Cell. Biol. 27: 2910-2918. (Pubitemid 46581306)
56. Bennett, E. J., and J. W. Harper. 2008. DNA damage: ubiquitin marks the spot. Nat. Struct. Mol. Biol. 15: 20-22.
57. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, and T. Taniguchi. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599.
58. Tanaka, N., M. Ishihara, M. S. Lamphier, H. Nozawa, T. Matsuyama, T. W. Mak, S. Aizawa, T. Tokino, M. Oren, and T. Taniguchi. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818. (Pubitemid 26299566)
59. Sims, S. H., Y. Cha, M. F. Romine, P. Q. Gao, K. Gottlieb, and A. B. Deisseroth. 1993. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13: 690-702. (Pubitemid 23006945)
60. Pine, R. 1997. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res. 25: 4346-4354. (Pubitemid 27485215)
61. Lu, R., P. A. Moore, and P. M. Pitha. 2002. Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility. J. Biol. Chem. 277: 16592-16598. (Pubitemid 34967676)
62. Wu, Z. H., Y. Shi, R. S. Tibbetts, and S. Miyamoto. 2006. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311: 1141-1146.
63. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27: 693-733.
64. Perkins, N. D. 2006. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730. (Pubitemid 44657848)
65. Harrison, J. C., and J. E. Haber. 2006. Surviving the breakup: the DNA damage checkpoint. Annu. Rev. Genet. 40: 209-235. (Pubitemid 44956785)
66. Nyberg, K. A., R. J. Michelson, C. W. Putnam, and T. A. Weinert. 2002. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36: 617-656. (Pubitemid 36109200)
67. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8: 49-62. (Pubitemid 46012014)
68. Stilmann, M., M. Hinz, S. C. Arslan, A. Zimmer, V. Schreiber, and C. Scheidereit. 2009. A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol. Cell 36: 365-378.
69. Chun, H. H., and R. A. Gatti. 2004. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst.) 3: 1187-1196. (Pubitemid 38997962)
70. Lavin, M. F. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9: 759-769.
71. Liu, M., B. T. Hummer, X. Li, and B. A. Hassel. 2004. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J. Interferon Cytokine Res. 24: 647-654. (Pubitemid 39546351)
72. Townsend, P. A., M. S. Cragg, S. M. Davidson, J. McCormick, S. Barry, K. M. Lawrence, R. A. Knight, M. Hubank, P. L. Chen, D. S. Latchman, and A. Stephanou. 2005. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J. Cell Sci. 118: 1629-1639. (Pubitemid 40691891)
73. Tsai, M. H., J. A. Cook, G. V. Chandramouli, W. DeGraff, H. Yan, S. Zhao, C. N. Coleman, J. B. Mitchell, and E. Y. Chuang. 2007. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 67: 3845-3852. (Pubitemid 46762172)
74. Weichselbaum, R. R., H. Ishwaran, T. Yoon, D. S. Nuyten, S. W. Baker, N. Khodarev, A. W. Su, A. Y. Shaikh, P. Roach, B. Kreike, et al. 2008. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc. Natl. Acad. Sci. USA 105: 18490-18495.
75. Shirata, N., A. Kudoh, T. Daikoku, Y. Tatsumi, M. Fujita, T. Kiyono, Y. Sugaya, H. Isomura, K. Ishizaki, and T. Tsurumi. 2005. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J. Biol. Chem. 280: 30336-30341. (Pubitemid 41216214)
76. Lilley, C. E., M. S. Chaurushiya, and M. D. Weitzman. 2010. Chromatin at the intersection of viral infection and DNA damage. Biochim. Biophys. Acta 1799: 319-327.
77. Evans, J. D., and P. Hearing. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79: 6207-6215. (Pubitemid 40617225)
78. Stracker, T. H., C. T. Carson, and M. D. Weitzman. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418: 348-352. (Pubitemid 34790688)
79. Lilley, C. E., M. S. Chaurushiya, C. Boutell, S. Landry, J. Suh, S. Panier, R. D. Everett, G. S. Stewart, D. Durocher, and M. D. Weitzman. 2010. Aviral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J. 29: 943-955.
80. Moiseeva, O., F. A. Mallette, U. K. Mukhopadhyay, A. Moores, and G. Ferbeyre. 2006. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 17: 1583-1592. (Pubitemid 44011578)
81. Takaoka, A., S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, H. Kikuchi, S. Sasaki, K. Imai, T. Shibue, K. Honda, and T. Taniguchi. 2003. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516-523. (Pubitemid 36975769)
82. Thyrell, L., S. Erickson, B. Zhivotovsky, K. Pokrovskaja, O. Sangfelt, J. Castro, S. Einhorn, and D. Grandér. 2002. Mechanisms of Interferon-alpha induced apoptosis in malignant cells. Oncogene 21: 1251-1262. (Pubitemid 34185242)
83. Gomez, D., and N. C. Reich. 2003. Stimulation of primary human endothelial cell proliferation by IFN. J. Immunol. 170: 5373-5381. (Pubitemid 36617822)
84. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14: 432-436. (Pubitemid 34671244)
85. Prchal, M., A. Pilz, O. Simma, K. Lingnau, A. von Gabain, B. Strobl, M. Müller, and T. Decker. 2009. Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity. Vaccine 27(Suppl. 6): G17-G20.)